Serveur d'exploration sur la COVID en France - Exploration (Accueil)

Index « Titre (en) » - entrée « inhibitors »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
inhibitor < inhibitors < inhibitory  Facettes :

List of bibliographic references indexed by inhibitors

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000222 (2020) J-B De Fréminville [France] ; M. Azizi [France][Are renin-angiotensin system inhibitors protective or deleterious in patients with COVID-19?]
000533 (2020) Rostom Ahmed-Belkacem [France] ; Priscila Sutto-Ortiz [France] ; Mathis Guiraud [France] ; Bruno Canard [France] ; Jean-Jacques Vasseur [France] ; Etienne Decroly [France] ; Françoise Debart [France]Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase.
000534 (2020) Pierre Miossec [France]Synergy between cytokines and risk factors in the cytokine storm of Covid-19: protection from the chronic use of cytokine inhibitors?
000847 (2020) Bruno Charpiat [France] ; Nathalie Bleyzac [France] ; Michel Tod [France]Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?
000C66 (2020) Jean-Jacques Mourad [France] ; Bernard I. Levy [France]Interaction between RAAS inhibitors and ACE2 in the context of COVID-19.
000C74 (2020) Christian Jung [Allemagne] ; Raphael Romano Bruno [Allemagne] ; Bernhard Wernly [Autriche] ; Michael Joannidis [Autriche] ; Sandra Oeyen [Belgique] ; Tilemachos Zafeiridis [Grèce] ; Brian Marsh [Irlande (pays)] ; Finn H. Andersen [Norvège] ; Rui Moreno [Portugal] ; Ana Margarida Fernandes [Portugal] ; Antonio Artigas [Espagne] ; Bernardo Bollen Pinto [Suisse] ; Joerg Schefold [Suisse] ; Georg Wolff [Allemagne] ; Malte Kelm [Allemagne] ; Dylan W. De Lange [Pays-Bas] ; Bertrand Guidet [France] ; Hans Flaatten [Norvège] ; Jesper Fj Lner [Danemark]Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19 in critically ill elderly patients.
000D00 (2020) Franck Touret [France] ; Magali Gilles [France] ; Karine Barral [France] ; Antoine Nougairède [France] ; Jacques Van Helden [France] ; Etienne Decroly [France] ; Xavier De Lamballerie [France] ; Bruno Coutard [France]In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication.
000D72 (2020) Michele Maio [Italie] ; Omid Hamid [États-Unis] ; James Larkin [Royaume-Uni] ; Alessia Covre [Italie] ; Maresa Altomonte [Italie] ; Luana Calabr [Italie] ; Santosh A. Vardhana [États-Unis] ; Caroline Robert [France] ; Ramy Ibrahim [États-Unis] ; Andrea Anichini [Italie] ; Jedd D. Wolchok [États-Unis] ; Anna Maria Di Giacomo [Italie]Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era.
000D74 (2020) S. Voicu [France] ; M. Delrue ; B G Chousterman ; A. Stépanian ; P. Bonnin ; I. Malissin ; N. Deye ; M. Neuwirth ; C. Ketfi ; A. Mebazaa ; V. Siguret ; B. MégarbaneImbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
001118 (2020) Joseph Kattan [Liban] ; Clarisse Kattan [Liban] ; Tarek Assi [Liban]Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection?
001517 (2020) Alessandro Leonetti [Italie] ; Francesco Facchinetti [Italie] ; Teresa Zielli [Italie] ; Elena Brianti [Italie] ; Marcello Tiseo [Italie]COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors.
001666 (2020) Sophie Liabeuf [France] ; Julien Moragny [France] ; Youssef Bennis [France] ; Benjamin Batteux [France] ; Etienne Brochot [France] ; Jean Luc Schmit [France] ; Jean-Philippe Lanoix [France] ; Claire Andrejak [France] ; Olivier Ganry [France] ; Michel Slama [France] ; Julien Maizel [France] ; Yazine Mahjoub [France] ; Kamel Masmoudi [France] ; Valérie Gras-Champel [France]Association between renin-angiotensin system inhibitors and COVID-19 complications.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "inhibitors" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    inhibitors
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021